CLE Adverse Event Reporting 3 — Questions and Answers
Question 1: A breastfeeding mother reports a rash after using a lanolin-based nipple cream. The CLE suspects an allergic contact dermatitis. Which body oversees adverse event reports for this type of topical product?
- Consumer Product Safety Commission (CPSC)
- FDA Center for Drug Evaluation and Research (CDER) or CFSAN depending on product classification (Correct answer)
- EPA because lanolin is derived from animal sources
- USDA because the product involves a dairy-related substance
Correct answer: FDA Center for Drug Evaluation and Research (CDER) or CFSAN depending on product classification
Nipple creams may be regulated as OTC drugs (CDER) or cosmetics (CFSAN) depending on their claims, so the appropriate FDA center depends on product classification.
Question 2: Which statement about voluntary versus mandatory adverse event reporting is CORRECT in the US context?
- Voluntary reports from consumers carry no weight in FDA signal detection
- Mandatory reporting applies only to hospitals, not outpatient lactation practices
- Manufacturers must report serious device-related events; healthcare providers may report voluntarily (Correct answer)
- Voluntary MedWatch reports are automatically dismissed unless supported by a physician
Correct answer: Manufacturers must report serious device-related events; healthcare providers may report voluntarily
Under FDA regulations, device manufacturers and importers have mandatory reporting obligations, while healthcare professionals and consumers report voluntarily through MedWatch.
Question 3: After a breastfeeding infant is diagnosed with methemoglobinemia potentially linked to a nipple cleaning solution, the CLE should prioritize which action?
- Advise the family to sue the manufacturer before filing any report
- Preserve the product sample and lot number, then file a MedWatch report (Correct answer)
- Discard the product to prevent further exposure and close the case
- Wait for the pediatrician to file a report before taking any action
Correct answer: Preserve the product sample and lot number, then file a MedWatch report
Preserving product evidence and reporting to FDA MedWatch are critical steps when a product is suspected of causing a serious infant adverse event.
Question 4: A CLE working in a hospital notices a cluster of three infants with feeding difficulties all using the same silicone bottle nipple brand. What is the MOST appropriate escalation?
- Discuss the cluster informally at the next staff meeting and monitor for more cases
- Report the cluster to the FDA as a potential signal, referencing all three cases (Correct answer)
- Contact the manufacturer's sales representative for a replacement
- Remove the product from the unit without any formal documentation
Correct answer: Report the cluster to the FDA as a potential signal, referencing all three cases
A cluster of similar adverse events with the same device constitutes a signal that should be formally reported to the FDA to trigger investigation.
Question 5: Which international framework guides pharmacovigilance standards that may influence how a US-based CLE understands global adverse event reporting?
- WHO Programme for International Drug Monitoring (Uppsala Monitoring Centre) (Correct answer)
- OECD Guidelines for Testing of Chemicals
- ISO 9001 Quality Management Systems
- UNICEF Baby-Friendly Hospital Initiative
Correct answer: WHO Programme for International Drug Monitoring (Uppsala Monitoring Centre)
The WHO Uppsala Monitoring Centre coordinates international pharmacovigilance, establishing global standards that inform drug safety monitoring worldwide.
Question 6: When a CLE documents an adverse event in a client's electronic health record (EHR), which principle of documentation best supports a future regulatory report?
- Use abbreviations freely to save charting time
- Record objective findings with timestamps, product identifiers, and the client's verbatim account (Correct answer)
- Summarize the event in one sentence to avoid lengthy records
- Delay documentation until the outcome is fully known
Correct answer: Record objective findings with timestamps, product identifiers, and the client's verbatim account
Detailed, contemporaneous EHR documentation with product identifiers and verbatim client statements provides the most defensible basis for regulatory reporting.
Question 7: A galactogogue herbal supplement causes liver enzyme elevation in a nursing mother. Which FDA reporting program specifically addresses dietary supplement adverse events?
- VAERS
- MedWatch/CFSAN Adverse Event Reporting System (CAERS) (Correct answer)
- Sentinel Initiative
- Drug Abuse Warning Network (DAWN)
Correct answer: MedWatch/CFSAN Adverse Event Reporting System (CAERS)
CAERS (CFSAN Adverse Event Reporting System) is the FDA database for adverse events related to foods, dietary supplements, and cosmetics.
CLE Adverse Event Reporting 3
A breastfeeding mother reports a rash after using a lanolin-based nipple cream.
The CLE suspects an allergic contact dermatitis.
Which body oversees adverse event reports for this type of topical product?